Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sander

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Molecular Microbiology|June 16, 2010
Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosisDmitri Shcherbakov, Rashid Akbergenov, Tanja Matt, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Rifabutin Is Inactivated by Mycobacterium abscessus ArrDaniel Schäfle, Petra Selchow, Barbara Borer, et al.
EMBO Reports|August 28, 2010
Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathwayFrank Imkamp, Frank Striebel, Markus Sutter, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Fitness cost of chromosomal drug resistance-conferring mutationsPeter Sander, Burkhard Springer, Therdsak Prammananan, et al.
Nucleic Acids Research|June 18, 2025
Selective inhibition of Mycobacterium tuberculosis GpsI unveils a novel strategy to target the RNA metabolismTizian Griesser, Rui Wang, Irene Pachon Angona, et al.
Molecular Microbiology|September 3, 2004
Lack of mismatch correction facilitates genome evolution in mycobacteriaBurkhard Springer, Peter Sander, Ludwig Sedlacek, et al.
Molecular Microbiology|November 2, 2002
DNA damage induction of recA in Mycobacterium tuberculosis independently of RecA and LexAElaine O Davis, Burkhard Springer, Krishna K Gopaul, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNASven N Hobbie, Peter Pfister, Christian Bruell, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 16, 2019
Identification of novel scaffolds targeting Mycobacterium tuberculosisMichael Dal Molin, Petra Selchow, Daniel Schäfle, et al.
The FEBS Journal|January 22, 2009
Polyphosphates from Mycobacterium bovis--potent inhibitors of class III adenylate cyclasesYing Lan Guo, Hermann Mayer, Waldemar Vollmer, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Molecular Microbiology|June 16, 2010
Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosisDmitri Shcherbakov, Rashid Akbergenov, Tanja Matt, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Rifabutin Is Inactivated by Mycobacterium abscessus ArrDaniel Schäfle, Petra Selchow, Barbara Borer, et al.
EMBO Reports|August 28, 2010
Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathwayFrank Imkamp, Frank Striebel, Markus Sutter, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Fitness cost of chromosomal drug resistance-conferring mutationsPeter Sander, Burkhard Springer, Therdsak Prammananan, et al.
Nucleic Acids Research|June 18, 2025
Selective inhibition of Mycobacterium tuberculosis GpsI unveils a novel strategy to target the RNA metabolismTizian Griesser, Rui Wang, Irene Pachon Angona, et al.
Molecular Microbiology|September 3, 2004
Lack of mismatch correction facilitates genome evolution in mycobacteriaBurkhard Springer, Peter Sander, Ludwig Sedlacek, et al.
Molecular Microbiology|November 2, 2002
DNA damage induction of recA in Mycobacterium tuberculosis independently of RecA and LexAElaine O Davis, Burkhard Springer, Krishna K Gopaul, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNASven N Hobbie, Peter Pfister, Christian Bruell, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 16, 2019
Identification of novel scaffolds targeting Mycobacterium tuberculosisMichael Dal Molin, Petra Selchow, Daniel Schäfle, et al.
The FEBS Journal|January 22, 2009
Polyphosphates from Mycobacterium bovis--potent inhibitors of class III adenylate cyclasesYing Lan Guo, Hermann Mayer, Waldemar Vollmer, et al.
Pageof 10